1.25 USD
+0.02 (+1.63%)
1.25 USD
0 (0%)
CTEK gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 103 industry peers in the Health Care Providers & Services industry. The financial health of CTEK is average, but there are quite some concerns on its profitability. CTEK does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
- In the past year CTEK has reported negative net income.
1.2 Ratios
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -55.8% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | -43.25% | ||
| PM (TTM) | -61.88% | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- CTEK does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, CTEK has more shares outstanding
- Compared to 1 year ago, CTEK has an improved debt to assets ratio.
2.2 Solvency
- Based on the Altman-Z score of 0.99, we must say that CTEK is in the distress zone and has some risk of bankruptcy.
- CTEK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.99 |
ROIC/WACCN/A
WACC8.29%
2.3 Liquidity
- CTEK has a Current Ratio of 1.69. This is a normal value and indicates that CTEK is financially healthy and should not expect problems in meeting its short term obligations.
- CTEK has a Quick Ratio of 1.69. This is a normal value and indicates that CTEK is financially healthy and should not expect problems in meeting its short term obligations.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.69 | ||
| Quick Ratio | 1.69 |
3. Growth
3.1 Past
- The earnings per share for CTEK have decreased strongly by -52.63% in the last year.
- Looking at the last year, CTEK shows a decrease in Revenue. The Revenue has decreased by -2.26% in the last year.
- Measured over the past years, CTEK shows a very negative growth in Revenue. The Revenue has been decreasing by -22.99% on average per year.
EPS 1Y (TTM)-52.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16037.89%
Revenue 1Y (TTM)-2.26%
Revenue growth 3Y-8.55%
Revenue growth 5Y-22.99%
Sales Q2Q%1.76%
3.2 Future
- The Earnings Per Share is expected to grow by 34.71% on average over the next years. This is a very strong growth
- The Revenue is expected to grow by 17.89% on average over the next years. This is quite good.
EPS Next Y-23.1%
EPS Next 2Y-2.72%
EPS Next 3Y36.03%
EPS Next 5Y34.71%
Revenue Next Year16.51%
Revenue Next 2Y18.47%
Revenue Next 3Y17.7%
Revenue Next 5Y17.89%
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- CTEK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year CTEK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | -2.57 |
4.3 Compensation for Growth
- A more expensive valuation may be justified as CTEK's earnings are expected to grow with 36.03% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.72%
EPS Next 3Y36.03%
5. Dividend
5.1 Amount
- No dividends for CTEK!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
CYNERGISTEK INC/DE / CTEK FAQ
What is the ChartMill fundamental rating of CYNERGISTEK INC/DE (CTEK) stock?
ChartMill assigns a fundamental rating of 3 / 10 to CTEK.
Can you provide the valuation status for CYNERGISTEK INC/DE?
ChartMill assigns a valuation rating of 2 / 10 to CYNERGISTEK INC/DE (CTEK). This can be considered as Overvalued.
What is the profitability of CTEK stock?
CYNERGISTEK INC/DE (CTEK) has a profitability rating of 1 / 10.
Can you provide the expected EPS growth for CTEK stock?
The Earnings per Share (EPS) of CYNERGISTEK INC/DE (CTEK) is expected to decline by -23.1% in the next year.